Furthermore, PTP1B inhibition seems to pose a risk for hyperinflammation in case of a simultaneous infection, indicated by the increased PTP1B inhibition resulting in an extremely increased IL-8 release triggered by the combination of LPS and the PTP1B inhibitor. Here, CXCL8 is linked to infection.